Baber, Tooba  <br/><br/>
MRCP :   rapid review /  
Tooba Baber. 
 - First edition. 
 - Lahore,   Baber Enterprises:  2025. 
 - 212 pages,  21.7 cm 
<br/><br/> DC011225 
<br/><br/> MRCP Rapid Review focuses on the highest-yield clinical facts: Heart failure is treated with ACEi/ARB/ARNI, β-blockers and MRAs; ACS needs dual antiplatelet therapy and early PCI; AF anticoagulation is based on CHA₂DS₂-VASc. Asthma is reversible while COPD is irreversible, and PE is confirmed with CTPA. UC has continuous lesions from the rectum, whereas Crohn’s shows skip lesions. Addison’s presents with hyperpigmentation and electrolyte imbalance, and thyroid storm needs urgent β-blockers and antithyroid drugs. Stroke requires urgent CT and possible thrombolysis. AKI is often pre-renal, nephrotic syndrome causes heavy proteinuria, and hyperkalaemia is treated with calcium gluconate plus insulin/dextrose. Sepsis 6 guides early management, endocarditis uses Duke criteria, and TB is treated with RIPE. RA is managed with methotrexate, SLE with hydroxychloroquine, and gout with NSAIDs or allopurinol. Iron deficiency causes microcytosis, B12 deficiency causes neuropathy, AML shows Auer rods, CML has BCR-ABL responsive to imatinib, and cancer staging uses the TNM system. 
<br/><br/><br/>In English. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Internal medicine--Examinations--Study guides.<br/>Medicine--Review literature.
<br/><br/><label>Dewey Class. No.: </label>616  / BAB